179 related articles for article (PubMed ID: 36296501)
1. Computational Design, Synthesis, and Pharmacological Evaluation of Naproxen-Guaiacol Chimera for Gastro-Sparing Anti-Inflammatory Response by Selective COX2 Inhibition.
Shinu P; Sharma M; Gupta GL; Mujwar S; Kandeel M; Kumar M; Nair AB; Goyal M; Singh P; Attimarad M; Venugopala KN; Nagaraja S; Telsang M; Aldhubiab BE; Morsy MA
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296501
[TBL] [Abstract][Full Text] [Related]
2. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
Celotti F; Durand T
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
[TBL] [Abstract][Full Text] [Related]
3. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and in vivo pharmacological evaluation of novel mannich bases derived from 1,2,4-triazole containing a naproxen moiety.
Avci A; Taşci H; Kandemir Ü; Can ÖD; Gökhan-Kelekçi N; Tozkoparan B
Bioorg Chem; 2020 Jul; 100():103892. PubMed ID: 32388433
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen.
Bjarnason I; Macpherson A; Rotman H; Schupp J; Hayllar J
Scand J Gastroenterol; 1997 Feb; 32(2):126-30. PubMed ID: 9051872
[TBL] [Abstract][Full Text] [Related]
6. The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial.
Bias P; Buchner A; Klesser B; Laufer S
Am J Gastroenterol; 2004 Apr; 99(4):611-8. PubMed ID: 15089890
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, comparative docking, and pharmacological activity of naproxen amino acid derivatives as possible anti-inflammatory and analgesic agents.
Elhenawy AA; Al-Harbi LM; Moustafa GO; El-Gazzar MA; Abdel-Rahman RF; Salim AE
Drug Des Devel Ther; 2019; 13():1773-1790. PubMed ID: 31213767
[No Abstract] [Full Text] [Related]
8. Design, Synthesis and Pharmacological Evaluation of Gastro- Protective Anti-inflammatory Analgesic Agents based on Dual Oxidative Stress / Cyclooxygenase Inhibition.
Gaba M; Singh S; Mohan C; Dhingra R; Chauhan M; Rana P; Dhingra N
Antiinflamm Antiallergy Agents Med Chem; 2020; 19(3):268-290. PubMed ID: 30914035
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence.
Blackler R; Syer S; Bolla M; Ongini E; Wallace JL
PLoS One; 2012; 7(4):e35196. PubMed ID: 22496907
[TBL] [Abstract][Full Text] [Related]
10. Anticancer and Antimicrobial Activities of Naproxen and Naproxen Derivatives.
Han Mİ; Küçükgüzel ŞG
Mini Rev Med Chem; 2020; 20(13):1300-1310. PubMed ID: 32368976
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract.
Bjarnason I; Thjodleifsson B
Rheumatology (Oxford); 1999 May; 38 Suppl 1():24-32. PubMed ID: 10369403
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.
Cryer B; Feldman M
Am J Med; 1998 May; 104(5):413-21. PubMed ID: 9626023
[TBL] [Abstract][Full Text] [Related]
13. Transformation of Santonin to a Naproxen Analogue with Anti-Inflammatory Activity.
Singh R; Mandrah K; Asati A; Patel DK; Goel B; Vishwakarma RA; Roy SK; Jain SK
J Nat Prod; 2019 Jun; 82(6):1710-1713. PubMed ID: 31125226
[TBL] [Abstract][Full Text] [Related]
14. Naproxen sodium nanoparticles are less toxic and gastroprotective agents than the conventional NSAID drug naproxen sodium in Balb/c mice.
Razzaq A; Qureshi IZ
Toxicol Appl Pharmacol; 2022 Oct; 452():116192. PubMed ID: 35952772
[TBL] [Abstract][Full Text] [Related]
15. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
16. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
17. Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis.
Weideman RA; Kelly KC; Kazi S; Cung A; Roberts KW; Smith HJ; Sarosi GA; Little BB; Cryer B
Gastroenterology; 2004 Nov; 127(5):1322-8. PubMed ID: 15521001
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anti-inflammatory and ulcerogenic potential of zinc-ibuprofen and zinc-naproxen complexes in rats.
Jarosz M; Szkaradek N; Marona H; Nowak G; Młyniec K; Librowski T
Inflammopharmacology; 2017 Dec; 25(6):653-663. PubMed ID: 28536986
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
Lisse JR; Perlman M; Johansson G; Shoemaker JR; Schechtman J; Skalky CS; Dixon ME; Polis AB; Mollen AJ; Geba GP;
Ann Intern Med; 2003 Oct; 139(7):539-46. PubMed ID: 14530224
[TBL] [Abstract][Full Text] [Related]
20. NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects.
Davies NM; Røseth AG; Appleyard CB; McKnight W; Del Soldato P; Calignano A; Cirino G; Wallace JL
Aliment Pharmacol Ther; 1997 Feb; 11(1):69-79. PubMed ID: 9042976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
